Canada markets closed

Avricore Health Inc. (AVCR.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1850-0.0200 (-9.76%)
At close: 02:58PM EDT

Avricore Health Inc.

789 West Pender Street
Suite 1120
Vancouver, BC V6C 1H2

IndustryDiagnostics & Research
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Hector BremnerCEO & Director261.22kN/A1982
Ms. Kiriaki Smith CPA, CFO, CGA, CPACFO & Corp. Sec.144.18kN/A1967
Mr. Rodger SeccombeCTO & Director261.22kN/A1981
Mr. Will SeccombeCommunications AdvisorN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.


Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. It provides HealthTab, a turnkey point-of-care testing platform that turns pharmacies into community point-of-care diagnostic centers. The company has strategic partnerships with Shoppers Drug Marts and Abbott. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.

Corporate Governance

Avricore Health Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.